BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5939 related articles for article (PubMed ID: 3117468)

  • 21. A demonstration of a strain related restriction effect in the formation of experimental metastases.
    Jack AS; McVeigh KL
    J Pathol; 1987 May; 152(1):37-45. PubMed ID: 3625393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
    Böhm W; Thoma S; Leithäuser F; Möller P; Schirmbeck R; Reimann J
    J Immunol; 1998 Jul; 161(2):897-908. PubMed ID: 9670968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo reexpression of H-2 antigens in B16 melanoma cells.
    Lollini PL; Colombo MP; De Giovanni C; Nicoletti G; Parmiani G; Prodi G; Nanni P
    Exp Clin Immunogenet; 1985; 2(1):14-23. PubMed ID: 3939971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene.
    Lollini PL; Bosco MC; Cavallo F; De Giovanni C; Giovarelli M; Landuzzi L; Musiani P; Modesti A; Nicoletti G; Palmieri G
    Int J Cancer; 1993 Sep; 55(2):320-9. PubMed ID: 8370628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is mts1(S100A4) gene involved in the metastatic process modulated by gamma-interferon?
    Chiaramonte R; Fasola S; Lollini PL; De Giovanni C; Comi P
    Pathobiology; 1998; 66(1):38-40. PubMed ID: 9577965
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice.
    Takeda K; Nakayama M; Sakaki M; Hayakawa Y; Imawari M; Ogasawara K; Okumura K; Smyth MJ
    J Leukoc Biol; 2011 Oct; 90(4):777-85. PubMed ID: 21712396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.
    Mandelboim O; Vadai E; Feldman M; Eisenbach L
    Gene Ther; 1995 Dec; 2(10):757-65. PubMed ID: 8750016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced metastases of a mouse carcinoma after in vitro treatment with murine interferon gamma.
    Ramani P; Balkwill FR
    Int J Cancer; 1987 Dec; 40(6):830-4. PubMed ID: 3121523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A detailed study of the effects of in vitro interferon treatment on the growth of two variants of the B16 mouse melanoma in the lungs: evidence for non-specific effects.
    Blackmore M; Thompson S; Turner GA
    Clin Exp Metastasis; 1990; 8(5):449-60. PubMed ID: 2118016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
    Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
    Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
    Ziai MR; Imberti L; Tongson A; Ferrone S
    Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo H-2K and H-2D antigen expression in two allogeneic mouse tumours of low immunogenicity.
    Ashley MP; Kotlarski I
    Immunol Cell Biol; 1987 Aug; 65 ( Pt 4)():323-8. PubMed ID: 3679289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.
    Hafner M; Falk W; Echtenacher B; Männel DN
    Eur Cytokine Netw; 1999 Dec; 10(4):541-8. PubMed ID: 10586121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A weakly tumorigenic phenotype with high MHC class-I expression is associated with high metastatic potential after surgical removal of the primary murine fibrosarcoma.
    Pérez M; Algarra I; Ljunggren HG; Caballero A; Mialdea MJ; Gaforio JJ; Klein G; Kärre K; Garrido F
    Int J Cancer; 1990 Aug; 46(2):258-61. PubMed ID: 2116997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monophosphoryl lipid A (MPL) upregulates major histocompatibility complex (MHC) class I expression by increasing interferon-gamma (IFN-gamma).
    Cho CH; Lee BK; Kwak SM; Kim JD
    Yonsei Med J; 1999 Feb; 40(1):20-5. PubMed ID: 10198602
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transduction of genes coding for a histocompatibility (MHC) antigen and for its physiological inducer interferon-gamma in the same cell: efficient MHC expression and inhibition of tumor and metastasis growth.
    Lollini PL; De Giovanni C; Landuzzi L; Nicoletti G; Frabetti F; Cavallo F; Giovarelli M; Forni G; Modica A; Modesti A
    Hum Gene Ther; 1995 Jun; 6(6):743-52. PubMed ID: 7548274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
    Sibille C; Gould K; Hämmerling G; Townsend A
    Eur J Immunol; 1992 Feb; 22(2):433-40. PubMed ID: 1537379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
    Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
    Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The differential expression of H-2K versus H-2D antigens, distinguishing high-metastatic from low-metastatic clones, is correlated with the immunogenic properties of the tumor cells.
    Eisenbach L; Hollander N; Greenfeld L; Yakor H; Segal S; Feldman M
    Int J Cancer; 1984 Oct; 34(4):567-73. PubMed ID: 6490207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adoptive immunotherapy of metastatic B16 melanoma with allogeneic immune cells sensitized to minor histocompatibility antigens.
    Beatty PA; Greenberg PD; Cheever MA
    Transplantation; 1985 Feb; 39(2):182-6. PubMed ID: 3969713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 297.